Luster AD - Search Results

1

Antihistamines for cancer immunotherapy: More than just treating allergies.

Chen S, Luster AD. Chen S, et al. Among authors: luster ad. Cancer Cell. 2022 Jan 10;40(1):9-11. doi: 10.1016/j.ccell.2021.11.007. Epub 2021 Dec 2. Cancer Cell. 2022. PMID: 34861157 Free PMC article.

2

Antichemokine immunotherapy for allergic diseases.

Luster AD. Luster AD. Curr Opin Allergy Clin Immunol. 2001 Dec;1(6):561-7. doi: 10.1097/00130832-200112000-00012. Curr Opin Allergy Clin Immunol. 2001. PMID: 11964742 Review.

3

Chemokines in cancer.

Chow MT, Luster AD. Chow MT, et al. Among authors: luster ad. Cancer Immunol Res. 2014 Dec;2(12):1125-31. doi: 10.1158/2326-6066.CIR-14-0160. Cancer Immunol Res. 2014. PMID: 25480554 Free PMC article. Review.

4

The emergence of basophils as antigen-presenting cells in Th2 inflammatory responses.

Mikhak Z, Luster AD. Mikhak Z, et al. Among authors: luster ad. J Mol Cell Biol. 2009 Dec;1(2):69-71. doi: 10.1093/jmcb/mjp017. Epub 2009 Sep 23. J Mol Cell Biol. 2009. PMID: 19776083 Free PMC article.

5

Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.

Shea BS, Brooks SF, Fontaine BA, Chun J, Luster AD, Tager AM. Shea BS, et al. Among authors: luster ad. Am J Respir Cell Mol Biol. 2010 Dec;43(6):662-73. doi: 10.1165/rcmb.2009-0345OC. Epub 2010 Jan 15. Am J Respir Cell Mol Biol. 2010. PMID: 20081052 Free PMC article.

6

CXCR3 ligands: redundant, collaborative and antagonistic functions.

Groom JR, Luster AD. Groom JR, et al. Among authors: luster ad. Immunol Cell Biol. 2011 Feb;89(2):207-15. doi: 10.1038/icb.2010.158. Epub 2011 Jan 11. Immunol Cell Biol. 2011. PMID: 21221121 Free PMC article. Review.

7

CXCR3 in T cell function.

Groom JR, Luster AD. Groom JR, et al. Among authors: luster ad. Exp Cell Res. 2011 Mar 10;317(5):620-31. doi: 10.1016/j.yexcr.2010.12.017. Exp Cell Res. 2011. PMID: 21376175 Free PMC article.

8

Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes.

Sung JH, Zhang H, Moseman EA, Alvarez D, Iannacone M, Henrickson SE, de la Torre JC, Groom JR, Luster AD, von Andrian UH. Sung JH, et al. Among authors: luster ad. Cell. 2012 Sep 14;150(6):1249-63. doi: 10.1016/j.cell.2012.08.015. Cell. 2012. PMID: 22980984 Free PMC article.

9

Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.

Mikucki ME, Fisher DT, Matsuzaki J, Skitzki JJ, Gaulin NB, Muhitch JB, Ku AW, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS. Mikucki ME, et al. Among authors: luster ad. Nat Commun. 2015 Jun 25;6:7458. doi: 10.1038/ncomms8458. Nat Commun. 2015. PMID: 26109379 Free PMC article.

10

Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy.

Mikucki ME, Skitzki JJ, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS. Mikucki ME, et al. Among authors: luster ad. Oncoimmunology. 2016 Feb 11;5(5):e1116675. doi: 10.1080/2162402X.2015.1116675. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467928 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page